Latest Share Price Movement News

Spenda Limited has responded to an ASX price query following a notable rise in its share price and trading volume, denying any undisclosed material information while confirming ongoing confidential negotiations for virtual card and funding services.

Fenix Resources’ off-market takeover offer for CZR Resources has officially lapsed after failing to meet the 75% minimum acceptance threshold, leaving CZR shareholders in control of their stakes.

Aldoro Resources Limited has had its trading suspension lifted immediately following the release of new exploration results and a response to an ASX price query, signaling renewed market activity.

Polymetals Resources Ltd invites eligible shareholders to participate in a new Share Purchase Plan at $0.80 per share, aiming to raise up to $3.2 million after a successful $35 million institutional placement.

Infomedia Limited has announced an on-market share buyback of up to 5% of its issued capital, signalling confidence in its financial strength and commitment to shareholder value. The buyback will be executed over the next 12 months, leveraging the company’s robust cash reserves.

Fiducian Group Limited has announced a fully franked ordinary dividend of AUD 0.219 per share for the half-year ending December 2024, payable on March 17, 2025.

Recce Pharmaceuticals has temporarily paused trading of its securities, signaling a potentially significant development pending further disclosure.

Bapcor Limited will announce its half-year financial results for the period ending December 2024 on 26 February, with a live briefing hosted by its top executives.

GrainCorp Limited has announced an on-market buy-back of up to $50 million worth of its ordinary fully paid Class A shares, starting March 3, 2025. The move signals a strategic effort to enhance shareholder returns without specifying a fixed buy-back price or volume.

CAR Group Limited has announced a semi-annual ordinary dividend of AUD 0.385 per share, partially franked at 50%, payable in April 2025. Shareholders can opt into a Dividend Reinvestment Plan with no discount, reflecting steady shareholder returns.

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.

Maas Group Holdings has announced a fresh on-market share buyback of up to 10% of its issued capital, signaling strong confidence in its financial health and future prospects.